Clinical Trial Update: Patient-reported Outcomes in the Treatment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on patient-reported outcomes in schizophrenia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED